Abstract
Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the ABCD1 gene. Currently, the molecular mechanisms underlying the onset and severity of ALD still remain unclear. This study aimed to identify candidate genes associated with the onset and severity of ALD by performing transcriptome sequencing on whole blood samples from a family of monozygotic twins. By identifying differentially expressed genes (DEGs), performing set theory analysis, and gene enrichment analysis, researchers identified potential candidate genes. Five distinct sets of DEGs were identified from a family of identical twins with different onset ages and ABCD1 exon 2 deletion. Specifically, 39 DEGs and 425 DEGs were linked to the onset and severity of ALD. Key genes identified include C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69. Enrichment analysis suggested the roles of Ca2+ homeostasis and plasma membrane stability in disease progression.
Introduction
X-linked adrenoleukodystrophy (ALD) is a devastating neurogenetic disorder triggered by mutations in the ABCD1 gene. This genetic defect leads to the accumulation of very long-chain fatty acids (VLCFAs), which destroy the myelin sheath of nerves and damage the adrenal glands. A significant challenge in treating ALD is the "phenotype-genotype gap": individuals with the exact same ABCD1 mutation can exhibit vastly different clinical outcomes, ranging from asymptomatic adulthood to rapid childhood cerebral decline. This study investigates modifier genes that may influence these divergent paths using a unique twin-based model.
Study Design and Methods
The researchers utilized a "natural experiment" by studying a single family that included identical twins with the same genetic mutation but different clinical presentations. The cohort consisted of eight individuals, including symptomatic and asymptomatic carriers, as well as healthy controls.
To isolate the genetic signals responsible for disease onset, the team performed whole-blood transcriptome sequencing (RNA-seq). They employed set theory analysis to compare gene expression across five distinct groups to identify unique intersections of activity.
Key Insights and Results
By comparing the symptomatic twin against healthy controls and asymptomatic carriers, the researchers narrowed thousands of genes down to seven high-priority candidates: C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69.
Calcium Homeostasis and Membrane Stability
Gene Ontology (GO) and KEGG pathway enrichment analysis highlighted two critical biological areas: calcium (Ca2+) homeostasis and plasma membrane stability. Because VLCFA accumulation is known to destabilize membranes, these findings suggest that a patient's ability to maintain calcium balance under membrane stress may determine whether they remain asymptomatic or develop symptoms.
Immune System Involvement
Several of the identified genes, such as IL-26 and C4BPA, are linked to inflammation and the complement system. This reinforces the understanding of ALD as not just a metabolic disorder, but an active neuroinflammatory process.
Conclusion and Future Directions
This preliminary exploration identifies a specific set of 425 genes linked to the transition from an asymptomatic to an "illness" state. While the small sample size (one family) is a limitation, the identical twin model provides a powerful control for genetic background. Future research will focus on validating these seven candidate genes in larger cohorts and using functional assays to confirm their roles in ALD pathogenesis. These findings offer novel insights into the molecular mechanisms of ALD and potential targets for mitigating disease development.
Summary updated